Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
This session will explore the latest developments in immune therapies, focusing on novel approaches and their clinical applications. Discussions will include case studies and emerging trends in the field of immunotherapy.
This track aims to highlight the integration of clinical immunology research into everyday medical practice. Participants will discuss challenges and successes in translating immunological findings into effective treatments.
This session will delve into the identification and application of immune biomarkers for disease diagnosis and monitoring. Experts will present their findings on how these biomarkers can enhance precision medicine.
Focusing on the molecular underpinnings of immune regulation, this track will cover recent discoveries in cytokine signaling and immune checkpoint pathways. The implications of these mechanisms for therapeutic interventions will also be discussed.
This session will examine the concept of immune tolerance and its significance in autoimmune diseases and transplantation. Participants will explore strategies to manipulate immune tolerance for therapeutic purposes.
This track will investigate the interplay between cellular and humoral immunity in health and disease. Presentations will focus on how these interactions can inform treatment strategies.
This session will address the role of cytokine signaling in the immune response and its implications for various diseases. Researchers will present novel findings on cytokine networks and their therapeutic potential.
This track will explore the genetic basis of immune responses and susceptibility to diseases. Discussions will include advancements in genomics and their applications in immunotherapy.
Focusing on the design and execution of clinical trials for immunotherapeutic agents, this session will highlight both challenges and innovative solutions. Participants will share insights from recent trials and their outcomes.
This session will showcase cutting-edge immune diagnostic tools and techniques that enhance disease detection and monitoring. Experts will discuss the role of these diagnostics in improving patient outcomes.
This track will focus on the pathological aspects of immune responses in various diseases. Presentations will cover the mechanisms by which immune dysregulation contributes to disease progression.
SNRI maintains uninterrupted academic processes in the current global situation. Participants can engage and publish through online and blended conference formats.
PLEASE READ: CLOSING ENABLED IN 20S